UT
Ubix Therapeutics develops targeted anti-cancer drugs using proprietary drug delivery systems that enhance the efficacy of existing therapies. The company focuses on improving patient outcomes by increasing the precision of treatment while minimizing side effects associated with traditional cancer therapies.
Updated 4 months ago
Funding
$48M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Ubix Therapeutics develops targeted anti-cancer drugs using proprietary drug delivery systems that enhance the efficacy of existing therapies. The company focuses on improving patient outcomes by increasing the precision of treatment while minimizing side effects associated with traditional cancer therapies.